Evidence map›Paper›PMID 27887664›Full record

ArticleMedical education online2016

Translating sickle cell guidelines into practice for primary care providers with Project ECHO.

Lisa M Shook, Christina B Farrell, Karen A Kalinyak, Stephen C Nelson, Brandon M Hardesty, Angeli G Rampersad, Kay L Saving, Wanda J Whitten-Shurney, Julie A Panepinto, Russell E Ware and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Medical education online, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06562439 (Early Identification and Intervention Of Developmental Delay Among Infants And Toddlers With Sickle Cell Disease Using the Sickle Cell Caregiver Collaboration for Child Development), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06562439 nawithdrawnnot on this mapstarted 2025, after this paper: background citation

Early Identification and Intervention Of Developmental Delay Among Infants And Toddlers With Sickle Cell Disease Using the Sickle Cell Caregiver Collaboration for Child Development (SCCCD) Intervention

TypeinterventionalSponsorWashington University School of MedicineRan2025 to 2028Enrolled0ConditionsSickle Cell DiseaseArmsSickle Cell Collaboration for Child Development
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Expanding a Regional Sickle Cell Disease Project ECHOAdvances in medical education and practice · 2022
    Article
  10. Article
  11. Educational Needs of School Nurses Regarding the Evidence-Based Management of Sickle Cell Disease.International journal of environmental research and public health · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Lisa M ShookDepartment of Pediatrics, Cincinnati Comprehensive Sickle Cell Center, Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; lisa.shook@cchmc.org.
Christina B FarrellDepartment of Pediatrics, Cincinnati Comprehensive Sickle Cell Center, Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Karen A KalinyakDepartment of Pediatrics, Cincinnati Comprehensive Sickle Cell Center, Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Stephen C NelsonChildren's Hospitals and Clinics, Minneapolis, MN, USA.
Brandon M HardestyIndiana Hemophilia and Thrombosis Center, Inc., Indianapolis, IN, USA.
Angeli G RampersadIndiana Hemophilia and Thrombosis Center, Inc., Indianapolis, IN, USA.
Kay L SavingChildren's Hospital of Illinois, OSF Saint Francis Medical Center, University of Illinois College of Medicine, Peoria, IL, USA.
Wanda J Whitten-ShurneySickle Cell Disease Association of America, Michigan Chapter, Detroit, MI.
Julie A PanepintoChildren's Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI, USA.
Russell E WareDepartment of Pediatrics, Cincinnati Comprehensive Sickle Cell Center, Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Lori E CrosbyDivision of Behavioral Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Cincinnati Children's Hospital Medical Center · USIndiana Hemophilia and Thrombosis Center · USChildren’s Minnesota - St. Paul Hospital · USIllinois College · USMedical College of Wisconsin · USSickle Cell Disease Association of America · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundApproximately 100,000 persons with sickle cell disease (SCD) live in the United States, including 15,000 in the Midwest. Unfortunately, many patients experience poor health outcomes due to limited access to primary care providers (PCPs) who are prepared to deliver evidence-based SCD care. Sickle Treatment and Outcomes Research in the Midwest (STORM) is a regional network established to improve care and outcomes for individuals with SCD living in Indiana, Illinois, Michigan, Minnesota, Ohio, and Wisconsin.

methodsSTORM investigators hypothesized that Project ECHO

resultsNetwork leads in each of the STORM states assisted with developing the curriculum and are recruiting providers for monthly clinics. To assess STORM TeleECHO feasibility and acceptability, monthly attendance and satisfaction data are collected. Changes in self-reported knowledge, comfort, and practice patterns will be compared with pre-participation, and 6 and 12 months after participation.

conclusionsSTORM TeleECHO has the potential to increase implementation of the NHLBI evidence-based guidelines, especially increased use of hydroxyurea, resulting in improvements in the quality of care and outcomes for children and young adults with SCD. This model could be replicated in other pediatric chronic illness conditions to improve PCP knowledge and confidence in delivering evidence-based care.

Indexed as

Anemia, Sickle CellClinical CompetenceEducation, ContinuingEducation, DistanceEvidence-Based PracticePractice Guidelines as TopicPrimary Health CareProgram EvaluationSelf EfficacyUnited Statescontinuing educationprovider educationsickle cell diseasetelementoring

Identifiers

PMID27887664
PMCPMC5124118
OpenAlexW2551290641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.